Noland T A, Raynor R L, Jideama N M, Guo X, Kazanietz M G, Blumberg P M, Solaro R J, Kuo J F
Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Biochemistry. 1996 Nov 26;35(47):14923-31. doi: 10.1021/bi9616357.
The significance of site-specific phosphorylation by protein kinase C (PKC) isozymes alpha and delta and protein kinase A (PKA) of troponin I (TnI) and its phosphorylation site mutants in the regulation of Ca(2+)-stimulated MgATPase activity of reconstituted actomyosin S-1 was investigated. The genetically defined TnI mutants used were T144A, S43A/S45A, S43A/S45A/T144A (in which the PKC phosphorylation sites Thr-144 and Ser-43/Ser-45 were respectively substituted by Ala) and N32 (in which the first 32 amino acids in the NH2-terminal sequence containing Ser-23/Ser-24 were deleted). Although the PKC isozymes displayed different substrate phosphorylation kinetics, PKC-alpha phosphorylated equally well TnI wild type and all mutants, whereas N32 was a much poorer substrate for PKC-delta. Furthermore, the two PKC isozymes exhibited discrete specificities in phosphorylating distinct sites in TnI and its mutants, either as individual subunits or as components of the reconstituted troponin complex. Unlike PKC-alpha, PKC-delta favorably phosphorylated the PKA-preferred site Ser-23/Ser-24 and hence, like PKA, reduced the Ca2+ sensitivity of the reconstituted actomyosin S-1 MgATPase. In contrast, PKC-alpha preferred to phosphorylate Ser-43/Ser-45 (common sites for all isozymes) and thus reduced the maximal Ca(2+)-stimulated activity of the MgATPase. In this respect, PKC-delta, by cross-phosphorylating the PKA sites, functioned as a hybrid of PKC-alpha and PKA. The site specificities and hence functional differences between PKC-alpha and -delta were most evident at low phosphorylation (1 mol of phosphate/mol) of TnI wild type and were magnified when S43A/S45A and N32 were used as substrates. The present study has demonstrated, for the first time, that distinct functional consequences could arise from the site-selective preferences of PKC-alpha and -delta for phosphorylating a single substrate in the myocardium, i.e., TnI.
研究了蛋白激酶C(PKC)同工酶α和δ以及蛋白激酶A(PKA)对肌钙蛋白I(TnI)及其磷酸化位点突变体进行位点特异性磷酸化在调节重组肌动球蛋白S-1的Ca(2+)刺激的MgATPase活性中的意义。所使用的基因定义的TnI突变体为T144A、S43A/S45A、S43A/S45A/T144A(其中PKC磷酸化位点Thr-144和Ser-43/Ser-45分别被Ala取代)和N32(其中包含Ser-23/Ser-24的NH2末端序列中的前32个氨基酸被删除)。尽管PKC同工酶表现出不同的底物磷酸化动力学,但PKC-α对TnI野生型和所有突变体的磷酸化效果相同,而N32是PKC-δ的较差底物。此外,这两种PKC同工酶在磷酸化TnI及其突变体的不同位点时表现出不同的特异性,无论是作为单个亚基还是作为重组肌钙蛋白复合物的组成部分。与PKC-α不同,PKC-δ优先磷酸化PKA偏好的位点Ser-23/Ser-24,因此与PKA一样,降低了重组肌动球蛋白S-1 MgATPase的Ca2+敏感性。相反,PKC-α优先磷酸化Ser-43/Ser-45(所有同工酶的共同位点),从而降低了MgATPase的最大Ca(2+)刺激活性。在这方面,PKC-δ通过交叉磷酸化PKA位点,起到了PKC-α和PKA的混合作用。PKC-α和-δ之间的位点特异性以及因此产生的功能差异在TnI野生型的低磷酸化(1摩尔磷酸盐/摩尔)时最为明显,当使用S43A/S45A和N32作为底物时会放大。本研究首次证明,PKC-α和-δ对心肌中单一底物即TnI进行磷酸化的位点选择性偏好可能产生不同的功能后果。